$AVDL
AVADEL PHARMACEUTICALS PLC

2020 Q2 Form 10-Q Financial Statement

#000101247720000013 Filed on August 10, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $10.09M $17.55M
YoY Change -42.51% -39.95%
Cost Of Revenue $3.285M $3.622M
YoY Change -9.3% 3.13%
Gross Profit $6.806M $13.93M
YoY Change -51.15% -45.83%
Gross Profit Margin 67.45% 79.37%
Selling, General & Admin $7.095M $6.758M
YoY Change 4.99% -75.73%
% of Gross Profit 104.25% 48.51%
Research & Development $4.057M $10.29M
YoY Change -60.58% -13.44%
% of Gross Profit 59.61% 73.87%
Depreciation & Amortization $520.0K $690.0K
YoY Change -24.64% -62.09%
% of Gross Profit 7.64% 4.95%
Operating Expenses $11.15M $17.05M
YoY Change -34.59% -57.09%
Operating Profit $40.27M -$4.451M
YoY Change -1004.72% 59.82%
Interest Expense -$3.240M -$3.110M
YoY Change 4.18% 4.36%
% of Operating Profit -8.05%
Other Income/Expense, Net -$125.0K -$50.00K
YoY Change 150.0% -103.57%
Pretax Income $36.17M -$6.824M
YoY Change -629.98% 80.53%
Income Tax $5.292M $1.781M
% Of Pretax Income 14.63%
Net Earnings $30.87M -$8.605M
YoY Change -458.79% 150.29%
Net Earnings / Revenue 305.96% -49.02%
Basic Earnings Per Share $0.57 -$0.23
Diluted Earnings Per Share $0.49 -$0.23
COMMON SHARES
Basic Shares Outstanding 54.27M shares 37.36M shares
Diluted Shares Outstanding 69.94M shares 37.36M shares

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $238.6M $79.30M
YoY Change 200.88% -46.09%
Cash & Equivalents $102.2M $17.11M
Short-Term Investments $136.4M $62.20M
Other Short-Term Assets $294.0K $82.00K
YoY Change 258.54% -98.33%
Inventory $0.00 $2.601M
Prepaid Expenses $4.154M $2.594M
Receivables $5.692M $10.17M
Other Receivables $400.0K $2.000M
Total Short-Term Assets $277.0M $97.20M
YoY Change 185.0% -44.45%
LONG-TERM ASSETS
Property, Plant & Equipment $407.0K $934.0K
YoY Change -56.42% -61.71%
Goodwill $16.84M $18.49M
YoY Change -8.95% 0.0%
Intangibles $0.00 $1.224M
YoY Change -100.0% -98.28%
Long-Term Investments $1.500M $1.500M
YoY Change 0.0% -68.75%
Other Assets $37.62M $34.57M
YoY Change 8.8% 55.43%
Total Long-Term Assets $64.38M $68.51M
YoY Change -6.02% -43.03%
TOTAL ASSETS
Total Short-Term Assets $277.0M $97.20M
Total Long-Term Assets $64.38M $68.51M
Total Assets $341.4M $165.7M
YoY Change 106.02% -43.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.879M $4.798M
YoY Change 1.69% -57.04%
Accrued Expenses $15.82M $15.74M
YoY Change 0.53% -26.78%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $105.0K
YoY Change -100.0% -2.78%
Total Short-Term Liabilities $27.02M $33.58M
YoY Change -19.54% -34.94%
LONG-TERM LIABILITIES
Long-Term Debt $124.9M $118.6M
YoY Change 5.27% 4.95%
Other Long-Term Liabilities $5.292M $11.68M
YoY Change -54.67% -16.54%
Total Long-Term Liabilities $130.2M $130.3M
YoY Change -0.1% 2.58%
TOTAL LIABILITIES
Total Short-Term Liabilities $27.02M $33.58M
Total Long-Term Liabilities $130.2M $130.3M
Total Liabilities $159.3M $183.5M
YoY Change -13.19% -15.32%
SHAREHOLDERS EQUITY
Retained Earnings -$361.2M -$379.6M
YoY Change -4.85% 36.37%
Common Stock $615.8M $434.7M
YoY Change 41.68% 0.96%
Preferred Stock
YoY Change
Treasury Stock (at cost) $50.00M $50.00M
YoY Change 0.0% 0.0%
Treasury Stock Shares 5.407M shares 5.407M shares
Shareholders Equity $182.1M -$17.78M
YoY Change
Total Liabilities & Shareholders Equity $341.4M $165.7M
YoY Change 106.02% -43.87%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income $30.87M -$8.605M
YoY Change -458.79% 150.29%
Depreciation, Depletion And Amortization $520.0K $690.0K
YoY Change -24.64% -62.09%
Cash From Operating Activities -$7.780M -$1.440M
YoY Change 440.28% -92.77%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities -$80.89M $8.950M
YoY Change -1003.8% -58.55%
Cash From Investing Activities -$80.89M $8.950M
YoY Change -1003.8% 484.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 117.3M -30.00K
YoY Change -391133.33% -99.69%
NET CHANGE
Cash From Operating Activities -7.780M -1.440M
Cash From Investing Activities -80.89M 8.950M
Cash From Financing Activities 117.3M -30.00K
Net Change In Cash 28.64M 7.480M
YoY Change 282.89% -126.56%
FREE CASH FLOW
Cash From Operating Activities -$7.780M -$1.440M
Capital Expenditures $0.00 $0.00
Free Cash Flow -$7.780M -$1.440M
YoY Change 440.28% -1207.69%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Entity Central Index Key
EntityCentralIndexKey
0001012477
dei No Trading Symbol Flag
NoTradingSymbolFlag
true
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42720000 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63536000 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37313000 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
58129000 shares
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.068
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.146
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.164
CY2019Q2 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
23000 USD
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
41000 USD
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
488000 shares
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3622000 USD
CY2020Q2 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
81000 USD
CY2019Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.261
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
5407000 shares
CY2020Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
5407000 shares
us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
130000 USD
dei Document Type
DocumentType
10-Q
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5742000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6888000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9587000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17621000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4057000 USD
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7095000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22334000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33991000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3285000 USD
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
488000 shares
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
AVADEL PHARMACEUTICALS PLC
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
L2
dei Entity File Number
EntityFileNumber
000-28508
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1341933
dei Entity Address Address Line1
EntityAddressAddressLine1
10 Earlsfort Terrace
dei Entity Address City Or Town
EntityAddressCityOrTown
Dublin 2
dei Entity Address Country
EntityAddressCountry
IE
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
D02 T380
dei City Area Code
CityAreaCode
1
dei Local Phone Number
LocalPhoneNumber
485-1200
dei Security12b Title
Security12bTitle
Ordinary Shares, nominal value $0.01 per share**
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
58220634 shares
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10091000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17554000 USD
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6758000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15008000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
17204000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
203000 USD
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
204000 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10292000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
406000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
405000 USD
CY2020Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
918000 USD
CY2019Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
-377000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
3396000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1757000 USD
CY2020Q2 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
45760000 USD
CY2019Q2 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
45760000 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
CY2020Q2 us-gaap Restructuring Charges
RestructuringCharges
24000 USD
CY2019Q2 us-gaap Restructuring Charges
RestructuringCharges
1506000 USD
us-gaap Costs And Expenses
CostsAndExpenses
46609000 USD
us-gaap Restructuring Charges
RestructuringCharges
183000 USD
us-gaap Restructuring Charges
RestructuringCharges
2734000 USD
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
-30178000 USD
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
22005000 USD
us-gaap Costs And Expenses
CostsAndExpenses
-11438000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
40269000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4451000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
33772000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-12618000 USD
CY2020Q2 us-gaap Investment Income Net
InvestmentIncomeNet
-741000 USD
CY2019Q2 us-gaap Investment Income Net
InvestmentIncomeNet
950000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
-1119000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
1767000 USD
CY2020Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
3237000 USD
CY2019Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
3106000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
6427000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
6168000 USD
CY2020Q2 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0 USD
CY2019Q2 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
-167000 USD
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0 USD
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
-2840000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-125000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-50000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-435000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-357000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
36166000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6824000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
25791000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-20216000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5292000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1781000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4218000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1407000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
30874000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-8605000 USD
us-gaap Net Income Loss
NetIncomeLoss
30009000 USD
us-gaap Net Income Loss
NetIncomeLoss
-21623000 USD
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.58
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54272000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37356000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47665000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37355000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69942000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37356000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63083000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37355000 shares
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
30874000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-8605000 USD
us-gaap Net Income Loss
NetIncomeLoss
30009000 USD
us-gaap Net Income Loss
NetIncomeLoss
-21623000 USD
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
182000 USD
CY2019Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
62000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
5000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-99000 USD
CY2020Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
927000 USD
CY2019Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
293000 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
283000 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
667000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1109000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
355000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
288000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
568000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
31983000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8250000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
30297000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21055000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
102174000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9774000 USD
CY2020Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
136380000 USD
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
54384000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5692000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8281000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
0 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
3570000 USD
CY2020Q2 avdl Research And Development Tax Credit Receivable Current
ResearchAndDevelopmentTaxCreditReceivableCurrent
0 USD
CY2019Q4 avdl Research And Development Tax Credit Receivable Current
ResearchAndDevelopmentTaxCreditReceivableCurrent
2107000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32773000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4264000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
277019000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
82380000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
407000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
544000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3117000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3612000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
16836000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
18491000 USD
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
0 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
813000 USD
CY2020Q2 avdl Research And Development Tax Credit Receivable Non Current
ResearchAndDevelopmentTaxCreditReceivableNonCurrent
6407000 USD
CY2019Q4 avdl Research And Development Tax Credit Receivable Non Current
ResearchAndDevelopmentTaxCreditReceivableNonCurrent
6322000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
37615000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
39274000 USD
CY2020Q2 us-gaap Assets
Assets
341401000 USD
CY2019Q4 us-gaap Assets
Assets
151436000 USD
CY2020Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1914000 USD
CY2019Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
5554000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
563000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
645000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
4879000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6100000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15820000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19810000 USD
CY2020Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
354000 USD
CY2019Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
43000 USD
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3488000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3832000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
27018000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
35984000 USD
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
124879000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
121686000 USD
CY2020Q2 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
0 USD
CY2019Q4 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
11773000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2087000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2319000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5292000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8873000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
159276000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
180635000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
429000 USD
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
5000 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
635000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-22806000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-8605000 USD
CY2020Q2 us-gaap Treasury Stock Value
TreasuryStockValue
49998000 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
49998000 USD
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
615207000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
434391000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-361206000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-391215000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-22518000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
182125000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-29199000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
341401000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
151436000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-29199000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-865000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-821000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1389000 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
60733000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 USD
CY2020Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
88000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
742000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
32067000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
30874000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
30874000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1109000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
393000 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-94000 USD
CY2020Q2 avdl Stock Issued During Period Value Public Offering
StockIssuedDuringPeriodValuePublicOffering
116974000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
33000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
769000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
182125000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
2780000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-13018000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
213000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 USD
CY2019Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
92000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
351000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-9582000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
355000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
55000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-17777000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1550000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3127000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-6906000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3737000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
321000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-71000 USD
avdl Earn Out Payment In Excess Of Acquisition Date Fair Value
EarnOutPaymentInExcessOfAcquisitionDateFairValue
3736000 USD
avdl Earn Out Payment In Excess Of Acquisition Date Fair Value
EarnOutPaymentInExcessOfAcquisitionDateFairValue
5790000 USD
us-gaap Payments For Royalties
PaymentsForRoyalties
608000 USD
us-gaap Net Income Loss
NetIncomeLoss
30009000 USD
us-gaap Net Income Loss
NetIncomeLoss
-21623000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
975000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1064000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-478000 USD
avdl Acquisition Related Contingent Consideration Remeasurement
AcquisitionRelatedContingentConsiderationRemeasurement
3396000 USD
avdl Acquisition Related Contingent Consideration Remeasurement
AcquisitionRelatedContingentConsiderationRemeasurement
1757000 USD
avdl Financing Related Contingent Consideration Remeasurement
FinancingRelatedContingentConsiderationRemeasurement
435000 USD
avdl Financing Related Contingent Consideration Remeasurement
FinancingRelatedContingentConsiderationRemeasurement
357000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3193000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2918000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
161000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1900000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1511000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
406000 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
45760000 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 USD
us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
-1750000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
477000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-995000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2589000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-579000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1353000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2124000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1149000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1829000 USD
avdl Increase Decrease In Research And Development Tax Credit Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
-2036000 USD
avdl Increase Decrease In Research And Development Tax Credit Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
593000 USD
us-gaap Payments For Royalties
PaymentsForRoyalties
917000 USD
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
3458000 USD
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
3558000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19417000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22653000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
154000 USD
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
14500000 USD
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
15716000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
52202000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
97878000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
21991000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-67662000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
30336000 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
60639000 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
116974000 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1903000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
92000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-37000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
179516000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
55000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-37000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
48000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
92400000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7786000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9774000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9325000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
102174000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17111000 USD
us-gaap Interest Paid Net
InterestPaidNet
3234000 USD
us-gaap Interest Paid Net
InterestPaidNet
3234000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
-1795000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
140000 USD
avdl Foodand Drug Administration Approval Number Of Products
FoodandDrugAdministrationApprovalNumberOfProducts
3 FDA_drug
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
-2840000 USD
CY2020Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
0 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
135035000 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1354000 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
9000 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
136380000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
53238000 USD
CY2020Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1151000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
5000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
54384000 USD
CY2020Q2 avdl Marketable Securities Realized Gain
MarketableSecuritiesRealizedGain
14000 USD
CY2019Q2 avdl Marketable Securities Realized Gain
MarketableSecuritiesRealizedGain
174000 USD
CY2020Q2 avdl Marketable Securities Realized Loss
MarketableSecuritiesRealizedLoss
6000 USD
CY2019Q2 avdl Marketable Securities Realized Loss
MarketableSecuritiesRealizedLoss
0 USD
avdl Marketable Securities Realized Gain
MarketableSecuritiesRealizedGain
290000 USD
avdl Marketable Securities Realized Gain
MarketableSecuritiesRealizedGain
268000 USD
avdl Marketable Securities Realized Loss
MarketableSecuritiesRealizedLoss
878000 USD
avdl Marketable Securities Realized Loss
MarketableSecuritiesRealizedLoss
147000 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
3693000 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
8000 USD
CY2019Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
914000 USD
CY2020Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
0 USD
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3020000 USD
CY2020Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
0 USD
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
550000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
0 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
3570000 USD
CY2020Q2 us-gaap Goodwill Gross
GoodwillGross
16836000 USD
CY2020Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0 USD
CY2020Q2 us-gaap Goodwill
Goodwill
16836000 USD
CY2019Q4 us-gaap Goodwill Gross
GoodwillGross
18491000 USD
CY2019Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0 USD
CY2019Q4 us-gaap Goodwill
Goodwill
18491000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
203000 USD
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
204000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
406000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
405000 USD
CY2019Q4 us-gaap Business Combination Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
17327000 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
4344000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
3396000 USD
avdl Business Combination Financing Related Costs
BusinessCombinationFinancingRelatedCosts
435000 USD
us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
14900000 USD
CY2020Q2 us-gaap Business Combination Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
1914000 USD
CY2019Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
5554000 USD
CY2020Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1914000 USD
CY2019Q4 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
11773000 USD
CY2020Q2 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
0 USD
CY2020Q1 us-gaap Business Combination Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
18050000 USD
CY2020Q2 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
2279000 USD
CY2020Q2 us-gaap Business Combination Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
1914000 USD
CY2020Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
5855000 USD
CY2020Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
918000 USD
CY2020Q2 avdl Business Combination Financing Related Costs
BusinessCombinationFinancingRelatedCosts
125000 USD
CY2020Q2 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
14900000 USD
CY2020Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1914000 USD
CY2020Q1 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
12195000 USD
CY2020Q2 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
0 USD
CY2018Q4 us-gaap Business Combination Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
28840000 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
6707000 USD
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
2114000 USD
CY2019Q2 us-gaap Business Combination Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
24247000 USD
CY2019Q4 us-gaap Business Combination Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
17327000 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
4344000 USD
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
3831000 USD
us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
14900000 USD
CY2020Q2 us-gaap Business Combination Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
1914000 USD
CY2020Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
124879000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
121686000 USD
CY2020Q2 avdl Coronavirus Aid Relief And Economic Security Act Cares Act Changein Tax Rate Deferred Tax Liability Income Tax Benefit
CoronavirusAidReliefAndEconomicSecurityActCARESActChangeinTaxRateDeferredTaxLiabilityIncomeTaxBenefit
9124000 USD
CY2020Q2 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
266000 USD
CY2019Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
1051000 USD
CY2020Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4154000 USD
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2116000 USD
CY2020Q2 avdl Guarantee Current
GuaranteeCurrent
410000 USD
CY2019Q4 avdl Guarantee Current
GuaranteeCurrent
454000 USD
CY2020Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
149000 USD
CY2019Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
536000 USD
CY2020Q2 avdl Short Term Note Receivable
ShortTermNoteReceivable
27500000 USD
CY2019Q4 avdl Short Term Note Receivable
ShortTermNoteReceivable
0 USD
CY2020Q2 us-gaap Other Assets Current
OtherAssetsCurrent
294000 USD
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
107000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32773000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4264000 USD
CY2020Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
29180000 USD
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
29427000 USD
CY2020Q2 us-gaap Long Term Investments
LongTermInvestments
1477000 USD
CY2019Q4 us-gaap Long Term Investments
LongTermInvestments
1477000 USD
CY2020Q2 avdl Guarantee Noncurrent
GuaranteeNoncurrent
1184000 USD
CY2019Q4 avdl Guarantee Noncurrent
GuaranteeNoncurrent
1367000 USD
CY2020Q2 avdl Operating Lease Right Of Use Asset Contract Manufacturing Noncurrent
OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent
5201000 USD
CY2019Q4 avdl Operating Lease Right Of Use Asset Contract Manufacturing Noncurrent
OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent
6428000 USD
CY2020Q2 avdl Other Noncurrent Receivables
OtherNoncurrentReceivables
573000 USD
CY2019Q4 avdl Other Noncurrent Receivables
OtherNoncurrentReceivables
575000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
37615000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
39274000 USD
CY2020Q2 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
1432000 USD
CY2019Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
3944000 USD
CY2020Q2 avdl Accrued Social Charges
AccruedSocialCharges
219000 USD
CY2019Q4 avdl Accrued Social Charges
AccruedSocialCharges
592000 USD
CY2020Q2 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
1009000 USD
CY2019Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
2949000 USD
CY2020Q2 avdl Accrued Trade Discounts And Rebates
AccruedTradeDiscountsAndRebates
5901000 USD
CY2019Q4 avdl Accrued Trade Discounts And Rebates
AccruedTradeDiscountsAndRebates
6470000 USD
CY2020Q2 avdl Accrued Transaction Fees Current
AccruedTransactionFeesCurrent
2928000 USD
CY2020Q2 avdl Accrued Contract Research Organization Charges
AccruedContractResearchOrganizationCharges
1692000 USD
CY2019Q4 avdl Accrued Contract Research Organization Charges
AccruedContractResearchOrganizationCharges
2098000 USD
CY2020Q2 avdl Accrued Contract Manufacturing Organization Liabilities
AccruedContractManufacturingOrganizationLiabilities
260000 USD
CY2019Q4 avdl Accrued Contract Manufacturing Organization Liabilities
AccruedContractManufacturingOrganizationLiabilities
735000 USD
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2379000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3022000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15820000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19810000 USD
CY2020Q2 us-gaap Customer Refund Liability Noncurrent
CustomerRefundLiabilityNoncurrent
946000 USD
CY2019Q4 us-gaap Customer Refund Liability Noncurrent
CustomerRefundLiabilityNoncurrent
981000 USD
CY2020Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
3143000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
6465000 USD
CY2020Q2 us-gaap Guaranty Liabilities
GuarantyLiabilities
1188000 USD
CY2019Q4 us-gaap Guaranty Liabilities
GuarantyLiabilities
1372000 USD
CY2020Q2 us-gaap Other Long Term Debt
OtherLongTermDebt
15000 USD
CY2019Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
55000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5292000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8873000 USD
CY2020Q1 avdl Maximum Aggregate Offering Priceof Securities Under Shelf Registration
MaximumAggregateOfferingPriceofSecuritiesUnderShelfRegistration
250000 USD
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q1 avdl Maximum Aggregate Offering Priceof American Depositary Shares Under Shelf Registration
MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration
50000 USD
CY2020Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
328000 USD
CY2020Q1 avdl Maximum Threshold Percentage For Trigger Of Convertible Preferred Stock
MaximumThresholdPercentageForTriggerOfConvertiblePreferredStock
0.0999
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
30874000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-8605000 USD
us-gaap Net Income Loss
NetIncomeLoss
30009000 USD
us-gaap Net Income Loss
NetIncomeLoss
-21623000 USD
CY2020Q2 us-gaap Dilutive Securities
DilutiveSecurities
3237000 USD
CY2019Q2 us-gaap Dilutive Securities
DilutiveSecurities
0 USD
us-gaap Dilutive Securities
DilutiveSecurities
6427000 USD
us-gaap Dilutive Securities
DilutiveSecurities
0 USD
CY2020Q2 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
34111000 USD
CY2019Q2 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-8605000 USD
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
36436000 USD
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-21623000 USD
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54272000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37356000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47665000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37355000 shares
CY2020Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
15670000 shares
CY2019Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
15418000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69942000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37356000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63083000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37355000 shares
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.58
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2472 shares
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20359 shares
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2537 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20502 shares
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10091000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17554000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22334000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33991000 USD
avdl Percentage Of Royalty Payable On Net Sales
PercentageOfRoyaltyPayableOnNetSales
0.15
CY2020Q2 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
1599000 USD
CY2020Q2 avdl Guarantee Asset Current Carrying Value
GuaranteeAssetCurrentCarryingValue
1594000 USD

Files In Submission

Name View Source Status
0001012477-20-000013-index-headers.html Edgar Link pending
0001012477-20-000013-index.html Edgar Link pending
0001012477-20-000013.txt Edgar Link pending
0001012477-20-000013-xbrl.zip Edgar Link pending
avdl-20200630.xsd Edgar Link pending
avdl-20200630_cal.xml Edgar Link unprocessable
avdl-20200630_def.xml Edgar Link unprocessable
avdl-20200630_lab.xml Edgar Link unprocessable
avdl-20200630_pre.xml Edgar Link unprocessable
avdl2020q2.htm Edgar Link pending
avdl2020q2_htm.xml Edgar Link completed
exhibit102q22020.htm Edgar Link pending
exhibit311q22020.htm Edgar Link pending
exhibit312q22020.htm Edgar Link pending
exhibit321q22020.htm Edgar Link pending
exhibit322q22020.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending